Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence.
about
Dopamine dysregulation in a mouse model of paroxysmal nonkinesigenic dyskinesiaPhosphorylation of myofibrillogenesis regulator-1 activates the MAPK signaling pathway and induces proliferation and migration in human breast cancer MCF7 cellsMutations in FBXL4, encoding a mitochondrial protein, cause early-onset mitochondrial encephalomyopathyMutations in TTC19 cause mitochondrial complex III deficiency and neurological impairment in humans and fliesThe clinical and genetic heterogeneity of paroxysmal dyskinesias.Two-pore channels at the intersection of endolysosomal membrane trafficMutations in PNKD causing paroxysmal dyskinesia alters protein cleavage and stabilityMyofibrillogenesis regulator-1 overexpression is associated with poor prognosis of gastric cancer patientsClinicopathological and prognostic significance of myofibrillogenesis regulator-1 protein expression in pancreatic ductal adenocarcinomaLYRM7/MZM1L is a UQCRFS1 chaperone involved in the last steps of mitochondrial Complex III assembly in human cells.Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancerHigh expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomyAdult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variantThe genetics of dystonias.Milestones in dystonia.The genetics of dystonia: new twists in an old tale.Recessive mutations in MSTO1 cause mitochondrial dynamics impairment, leading to myopathy and ataxia.Myofibrillogenesis regulator 1 (MR-1): a potential therapeutic target for cancer and PNKD.The PNKD gene is associated with Tourette Disorder or Tic disorder in a multiplex family.
P2860
Q24300992-929ADA71-1E1F-4FD0-A629-A8DB22C4870EQ24301472-0B133BCE-74C5-4A0B-A53E-A46FE8125A1EQ24321305-EBE81F5D-C122-4CB5-97D1-9847A2F713D7Q24338706-A5D4A297-8E18-4D1B-873C-794F0009F0B5Q26776399-6A300C69-5469-449D-9CAC-C02E1EA0F117Q28085768-FB3973ED-51A8-442F-8ED7-8562150C7D4EQ28235413-4AB77A34-8078-4AAB-9DC1-4BBF7AFABDD9Q28277525-A7F3EE4A-CE64-4430-A1B5-ECBE57CF4695Q28291175-9A4D2141-8216-46C9-A1FA-3949BAAA9954Q32884553-875CD467-37B6-4BDB-9D31-BB06F0605580Q33942459-83434E16-0499-4B6B-A941-314952CE2205Q36464650-330E5FE0-79B2-4D4A-ADDD-68313A0A9E44Q36846924-4785947D-1EE8-4026-BA7B-97FC4994842BQ36934972-6650627A-693B-4D72-84AD-6B14F085C2C6Q37882600-73D16E3C-1200-4317-8393-8267129495A2Q38115272-ADE1DF4A-AA0C-4701-B6F9-5A7C80EB4E30Q41551921-E3012B82-1F63-4011-8E5C-9AFFBB03433DQ47441027-F833EC33-3463-47E8-A527-F3EA23EC8394Q47819833-AC327819-0B6B-4667-9D34-DC7D436393A8
P2860
Paroxysmal non-kinesigenic dyskinesia is caused by mutations of the MR-1 mitochondrial targeting sequence.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Paroxysmal non-kinesigenic dys ...... ochondrial targeting sequence.
@en
Paroxysmal non-kinesigenic dys ...... ochondrial targeting sequence.
@nl
type
label
Paroxysmal non-kinesigenic dys ...... ochondrial targeting sequence.
@en
Paroxysmal non-kinesigenic dys ...... ochondrial targeting sequence.
@nl
prefLabel
Paroxysmal non-kinesigenic dys ...... ochondrial targeting sequence.
@en
Paroxysmal non-kinesigenic dys ...... ochondrial targeting sequence.
@nl
P2093
P2860
P50
P356
P1476
Paroxysmal non-kinesigenic dys ...... ochondrial targeting sequence.
@en
P2093
Alessandra Ferlini
Carlo Viscomi
Domenico DeGrandis
Francesca Gualandi
P2860
P304
P356
10.1093/HMG/DDN441
P577
2009-01-05T00:00:00Z